Home            Contact us            FAQs
    
      Journal Home      |      Aim & Scope     |     Author(s) Information      |      Editorial Board      |      MSP Download Statistics

     Asian Journal of Medical Sciences


Interpretational Tool for Fertility Hormonal Profile Established from a Healthy Adult Kenyan Population

1Stanley King’e Waithaka, 2Eliud N. Njagi and 2Joseph N. Ngeranwa
1Department of Medical Laboratory Sciences, Mount Kenya University, 2Department of Biochemistry and Biotechnology, Kenyatta University, Nairobi, Kenya
Asian Journal of Medical Sciences  2019  2:6-12
http://dx.doi.org/10.19026/ajms.10.6013  |  © The Author(s) 2019
Received: August 2, 2018  |  Accepted: October 1, 2018  |  Published: July 25, 2019

Abstract

Infertility is a reproductive disorder that affects both male and female and prevents them from bearing desired child. Clinical laboratory plays a very important role in the process of investigating this disorder. A prospective study carried out in clinical chemistry laboratory of Kenyatta National Hospital involving 491 healthy individuals between 18-60 years. Reference ranges were constructed by using the parametric methods to estimate 2.5 and 97.5 percentiles of distribution as lower and upper reference limits. The fertility hormonal profile of the adult healthy Kenyan population was carried out by investigating luitenizing (LH), follicle stimulating (FSH), estradiol ii (EII), prolactin (PRL), progesterone PRG) and testosterone (TESTO) hormones; Four hundred and ninety-one voluntarily study subjects comprising of 221 males and 270 females were recruited in the study. Sex related reference values were established as follows:- TESTO [male (18-39 yrs [3.5-12.7 ng/mL], (40-50 yrs [2.5-6.9 ng/mL), (51-61 yrs [1.8-5.6 ng/mL] female: follicular and luteal phases [0-2 ng/mL], ovulation phase [0.7-3.3 ng/mL] and Menopause [0-1.17 ng/ml, FSH [male;[0.7-7.5 (μU/mL] female: follicular phase [4-16μU/mL, ovulation phase [5-20 μU/mL], luteal phases [2.5-7 μU/mL] and Menopause [0.11-1.89 μU/mL], LH [male;[ 0.5-5.7 μU/mL] female: follicular phase [0.7-8.6 μU/mL, ovulation phase [7-83μU/mL], luteal phase [0.4-6.8 μU/mL] and Menopause [0.13-2.18μU/mL], EII [male;[ 0-25 pg/mL]female: follicular phase[0-200 pg/mL], ovulation phase [134-467 pg/mL], luteal phases [75-351 pg/mL] and Menopause [1-17 pg/mL], PRG [male;[ 0.12-1.02 ng/mL]female: follicular phase [0.04-0.72 ng/mL], ovulation phase [0-5 ng/mL], luteal phases [0-0.38 ng/mL] and Menopause [0-0.38 ng/mL], PRL [male;[ 0-17 ng/mL]female: menstrual [1.7-23 ng/mL] and menopausal [8-29 ng/mL]. Bleeding period [menstrual [2-5 days].Sex specific reference ranges for the assessment of fertility and management of infertility disorders has been established. Age is an important factor in the interpretation of testosterone hormone in males. In females, the ovarian and pituitary fertility hormones have different reference ranges based on the phase of the menstrual cycle. These reference ranges are different from those reported in the literature, therefore clinical chemistry laboratories within the same geographical region should establish their own based on the population they serve.

Keywords:

Hormones, infertility, kenyatta national hospital, kenyan, laboratory, reference range,


References

  1. Heil, W., Koberstein and B. Zawta, 2002. Reference ranges for adults and children. 7th Edn., Roche Diagnostics GmbH Information Publication on Reference Ranges, pp:14-77.
  2. Andreeva, P., 2014. Thyroid gland and fertility. Akush Ginekol (Sofiia), 53(7): 18-23. (Article in Bulgarian)
  3. Burger, H.G., 1994. Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition--an analysis of FSH, oestradiol and inhibin. Eur. J. Endocrinol., 130(1): 38-42.
    CrossRef    
  4. Conneely, O.M., B. Mulac-Jericevic and J.P. Lydon, 2004. Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids, 68(10-13): 771-778.
    CrossRef    
  5. Dennerstein, L., J.L. Alexander and K. Kotz, 2003. The menopause and sexual functioning: A review of the population-based studies. Annu. Rev. Sex Res., 14: 64-82.
    Direct Link
  6. Ferraz-de-Souza, B., L. Lin and J.C. Achermann, 2011. Steroidogenic factor-1 (SF-1, NR5A1) and human disease. Mol. Cell. Endocrinol., 336(1-2): 198-205.
    CrossRef    PMid:21078366 PMCid:PMC3057017    
  7. Gurunath, S., Z. Pandian, R.A. Anderson and S. Bhattacharya, 2011. Defining infertility--a systematic review of prevalence studies. Hum. Reprod. Update, 17(5): 575-588.
    CrossRef    PMid:21493634    
  8. Jangir, R.N. and G.C. Jain, 2014. Diabetes mellitus induced impairment of male reproductive functions: A review. Curr. Diabetes Rev., 10(3): 147-157.
    CrossRef    PMid:24919656    
  9. Khetarpal, A. and S. Singh, 2012. Infertility: Why can't we classify this inability as disability? Australas. Med. J., 5(6): 334-339.https://doi.org/10.4066/AMJ.2012.1290
    CrossRef    PMid:22848333 PMCid:PMC3395292    
  10. Lis, R., A. Rowhani-Rahbar and L.E. Manhart, 2015. Mycoplasma genitalium infection and female reproductive tract disease: A meta-analysis. Clin. Infect. Dis., 61(3): 418-26.
    CrossRef    PMid:25900174    
  11. Livshits, A. and D.S. Seidman, 2009. Fertility issues in women with diabetes. Womens Health (Lond), 5(6): 701-707.
    CrossRef    PMid:19863473    
  12. Ljubin-Sternak, S. and T. Mestrovic, 2014. Chlamydia trachomatis and genital mycoplasmas: Pathogens with an impact on human reproductive health. J. Pathog., 2014: 183167.
    CrossRef    PMid:25614838 PMCid:PMC4295611    
  13. Mendiola, J., A.M. Torres-Cantero, J.M. Moreno-Grau, J. Ten, M. Roca, S. Moreno-Grau and R. Bernabeu, 2008. Exposure to environmental toxins in males seeking infertility treatment: A case-controlled study. Reprod. Biomed. Online, 16(6): 842-850.
    CrossRef    
  14. Restrepo, B. and W. Cardona-Maya, 2013. Antisperm antibodies and fertility association. Actas. Urol. Esp., 37(9): 571-578.https://doi.org/10.1016/j.acuroe.2012.11.016
    CrossRef    
  15. van den Boogaard, E., R. Vissenberg, J.A. Land, M. van Wely, J.A. van der Post, M. Goddijn and P.H. Bisschop, 2011. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: A systematic review. Hum. Reprod. Update, 17(5): 605-619.
    CrossRef    PMid:21622978    
  16. Zenzes, M.T., 2000. Smoking and reproduction: Gene damage to human gametes and embryos. Hum. Reprod. Update, 6(2): 122-131.https://doi.org/10.1093/humupd/6.2.122
    CrossRef    PMid:10782570    

Competing interests

The authors have no competing interests.

Open Access Policy

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Copyright

The authors have no competing interests.

ISSN (Online):  2040-8773
ISSN (Print):   2040-8765
Submit Manuscript
   Information
   Sales & Services
Home   |  Contact us   |  About us   |  Privacy Policy
Copyright © 2024. MAXWELL Scientific Publication Corp., All rights reserved